Is Novo Nordisk (NYSE:NVO) Pricing Fair After A 43% One Year Share Price Decline? [Yahoo! Finance]
Novo Nordisk A/S (NVO)
Last novo nordisk a/s earnings: 2/5 01:31 am
Check Earnings Report
US:NYSE Investor Relations:
novonordisk.com/investors.html
Company Research
Source: Yahoo! Finance
If you are wondering whether Novo Nordisk's current share price reflects its true worth, the recent performance offers a useful starting point for a closer look at valuation. The stock last closed at US$36.98, with returns of 1.6% over 7 days, 0.9% over 30 days, and larger declines of 29.4% year to date and 43.1% over 1 year. These moves sit against a backdrop where Novo Nordisk continues to attract attention as a large pharmaceuticals and biotech name on the NYSE, with ongoing interest in its product portfolio and long term healthcare trends. That context can help explain why some investors are reassessing both the potential and the risks around the current share price. On Simply Wall St's valuation checks, Novo Nordisk scores 5 out of 6 . The next sections will walk through what different valuation approaches suggest about the stock, and then conclude with a way to go beyond the numbers to understand the valuation story in full. Find out why Novo Nordisk's -43.1% return ove
Show less
Read more
Impact Snapshot
Event Time:
NVO
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
NVO alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
NVO alerts
High impacting Novo Nordisk A/S news events
Weekly update
A roundup of the hottest topics
NVO
News
- Novo Nordisk: Downgrading To 'Sell' As GLP-1 Pipeline Faces Many Risks [Seeking Alpha]Seeking Alpha
- Aspect Biosystems receives funding for cellular medicine project [Yahoo! Finance]Yahoo! Finance
- Novo Nordisk CEO says weight-loss drug boom has barely begun [Seeking Alpha]Seeking Alpha
- Eli Lilly's One-Two Punch Could Knock Novo Nordisk Out of the Obesity Drug Fight [Yahoo! Finance]Yahoo! Finance
- Asian travelers seek respite in other options as Middle East travel plans stay grounded Share Share VIDEO 9:54 09:54 How will Middle East flight disruptions and FX moves affect tourism in Asia? [CNBC]CNBC
NVO
Earnings
- 2/3/26 - Beat
NVO
Sec Filings
- 3/30/26 - Form 6-K
- 3/27/26 - Form 6-K
- 3/27/26 - Form 6-K
- NVO's page on the SEC website